The Administration on Aging defines a subcategory of elder abuse – “physical abuse” – as “inflicting physical pain or injury on a senior, e.g. slapping, bruising, or restraining by physical or chemical … [Read more...] about Elder Abuse in Nursing Facilities: The Over-Administration of Antipsychotic Drugs to Nursing Home Residents
Search Results for: antipsychotics
October 14, 2015 Andrew M. Slavitt Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Room 445-G, Hubert H. Humphrey Building 200 Independence Ave., S.W. Washington, D.C. … [Read more...] about CMA Comments on Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities
Last week’s Alert discussed the Centers for Medicare & Medicaid Services’ (CMS’s) National Partnership to Improve Dementia Care and the Government Accountability Office’s (GAO) recent report on antipsychotic … [Read more...] about Antipsychotic Drugs and Nursing Home Residents: What Do the Different Numbers Mean?
Centers for Medicare & Medicaid Services Department of Health & Human Services Attention: CMS-4159-P P.O. Box 8013 Baltimore, MD 21244-8013 March 7, 2014 Submitted Electronically: http://regulations.gov Re: CMS-4159-P To … [Read more...] about Center Comments on Proposed Medicare Part C & Part D Rules
As required by the 1987 federal Nursing Home Reform Law, CMS has developed, tested, and periodically revised a survey protocol that state surveyors, who are generally employed by the state health departments, must use to determine nursing … [Read more...] about CMA Report: Inappropriate Use of Antipsychotic Drugs in Nursing Homes, Part Three – Recommendations to Improve the Citing of Deficiencies
The recent settlement of criminal and civil charges against Johnson & Johnson for off-label marketing of Risperdal for nursing home residents once again brings the issue of antipsychotic drugs and nursing homes to public attention. A group … [Read more...] about Misuse of Antipsychotic Drugs in Nursing Homes: Are We Making Any Progress?
November 14, 2013 For Immediate Release Statement of California Advocates for Nursing Home Reform, Center for Medicare Advocacy, Legal Aid Justice Center, Long Term Care Community Coalition, The National Consumer Voice for Quality Long-Term … [Read more...] about $2.2 Billion Johnson & Johnson Settlement Sends New Warning: Antipsychotic Drugs Should Not Be Used to Treat Dementia
Examining Inappropriate Use of Antipsychotic Drugs, a Report in three Parts, looks at antipsychotic drug use in skilled nursing facilities (SNFs) and nursing facilities (NFs) from two perspectives. First, it analyzes the antipsychotic drug … [Read more...] about Examining Inappropriate Use of Antipsychotic Drugs, Part Two: How Surveyors Describe How, When, and Why They Cite Antipsychotic Drug Deficiencies (Note: Nearly 200 pages)
The misuse of antipsychotic drug is a pervasive problem in American nursing facilities. Misuse causes physical and psychological harm and death to residents and costs many hundreds of millions of dollars annually, both for the drugs … [Read more...] about Examining Inappropriate Use of Antipsychotic Drugs, Part One: How Seven States Cite Antipsychotic Drug Deficiencies
On May 31, 2012, the Centers for Medicare & Medicaid Services (CMS) announced an initiative to reduce the rampant misuse and overuse of antipsychotic drugs in nursing facilities. The Center for Medicare Advocacy has been working to educate … [Read more...] about Recognizing Elder Abuse Awareness Day: Working Together to Curb Misuse of Powerful Antipsychotic Drugs in Nursing Homes